Inventor
LANGSETH ABRAHAM J
US14 patents
Patents
14 patentsUS11819487B2Nov 21, 2023
Treatment of neurofibromatosis type 1 (NF1) associated plexiform neurofibromas (PN) in pediatric patients with mirdametinib
SPRINGWORKS THERAPEUTICS INC9 citations93
US11806321B2Nov 7, 2023
Non-linear dosing of mirdametinib
SPRINGWORKS THERAPEUTICS INC11 citations93
US12011424B2Jun 18, 2024
Treatment of neurofibromatosis type 1 (NF1) associated plexiform neurofibromas (PN) in pediatric patients with mirdametinib
SPRINGWORKS THERAPEUTICS INC4 citations84
US11806322B2Nov 7, 2023
Mirdametinib treatment
SPRINGWORKS THERAPEUTICS INC6 citations84
US12029711B1Jul 9, 2024
Dosage forms of mirdametinib
SPRINGWORKS THERAPEUTICS INC6 citations83
US11883375B2Jan 30, 2024
Mirdametinib treatment
SPRINGWORKS THERAPEUTICS INC2 citations82
US11839595B2Dec 12, 2023
Mirdametinib treatment
SPRINGWORKS THERAPEUTICS INC3 citations82
US12324791B2Jun 10, 2025
Mirdametinib treatment
SPRINGWORKS THERAPEUTICS INC1 citations73
US12295925B2May 13, 2025
Treatment of neurofibromatosis type 1 (NF1) associated plexiform neurofibromas (PN) in pediatric patients with mirdametinib
SPRINGWORKS THERAPEUTICS INC0 citations61
US12263146B2Apr 1, 2025
Non-linear dosing of mirdametinib
SPRINGWORKS THERAPEUTICS INC0 citations61
US12257215B2Mar 25, 2025
Mirdametinib treatment
SPRINGWORKS THERAPEUTICS INC0 citations61
US12220390B2Feb 11, 2025
Mirdametinib treatment
SPRINGWORKS THERAPEUTICS INC0 citations61
US12383517B2Aug 12, 2025
Dosage forms of mirdametinib
SPRINGWORKS THERAPEUTICS INC0 citations60
US12390430B1Aug 19, 2025
Mirdametinib treatment
SPRINGWORKS THERAPEUTICS INC0 citations51